Consistent with an immune-suppressive function of ADAR1 editing, some cancer cells become dependent on ADAR1 (Gannon et al. 2018) and loss of ADAR1 editing sensitizes tumors to immune checkpoint blockade (Ishizuka et al. 2019). Here, ADAR is linked to cancer.